Syros Pharmaceuticals, Inc. (LON: 0LC7)
London
· Delayed Price · Currency is GBP · Price in USD
0.206
-0.003 (-1.53%)
At close: Jan 21, 2025
Syros Pharmaceuticals Revenue
Syros Pharmaceuticals had revenue of $386.00K USD in the twelve months ending September 30, 2024, down -95.61% year-over-year. In the year 2023, Syros Pharmaceuticals had annual revenue of $9.94M, down -33.23%.
Revenue (ttm)
$386.00K
Revenue Growth
-95.61%
P/S Ratio
n/a
Revenue / Employee
$5.68K
Employees
68
Market Cap
4.48M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.94M | -4.94M | -33.23% |
Dec 31, 2022 | 14.88M | -8.61M | -36.65% |
Dec 31, 2021 | 23.49M | 8.40M | 55.62% |
Dec 31, 2020 | 15.09M | 13.11M | 661.50% |
Dec 31, 2019 | 1.98M | -68.00K | -3.32% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 221.41B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |